Fundraising Fox
Wellesley Pharmaceuticals
Newtown, US · Founded 2011 · 1 known investors
Find your way into Wellesley Pharmaceuticals
Sign up to see every warm intro you have to Wellesley Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Wellesley Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nocturol, Inc. (Wellesley Pharma) is developing a treatment for nocturia, a medical condition in which people are woken frequently at night by the need to urinate. The company targets the hundreds of millions of people who experience multiple nighttime bathroom visits.
Founders & leadership
DA
David Alan DillChief Executive Officer and President
Investors · 1
Reported raises · per SEC filings
Form D private placements$4.7M disclosed across 2 rounds · 2014–2015
▶$3.8MraisedOct 2017 · 14 investors · PharmaceuticalsRule 506(b)
▶$3.8MraisedOct 2017 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Christopher LineberryDirector
- Candan KarabagliDirector
- Omer KarahanDirector
- David Alan DillExecutive Officer, Director
- Offering amount
- $5.8M
- Amount sold
- $3.8M
- Sales commissions
- $150K
- Placement agents
- Healthcare Capital and Mergers
- First sale
- Mar 2015
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$934.9KraisedFeb 2015 · 18 investors · PharmaceuticalsRule 506(b)
▶$934.9KraisedFeb 2015 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David Alan DillExecutive Officer, Director
- Offering amount
- $3.4M
- Amount sold
- $934.9K
- Minimum investment
- $25K
- First sale
- Jul 2014
- Incorporated
- Limited Liability Company, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Wellesley Pharmaceuticals do?
- Nocturol, Inc. (Wellesley Pharma) is developing a treatment for nocturia, a medical condition in which people are woken frequently at night by the need to urinate. The company targets the hundreds of millions of people who experience multiple nighttime bathroom visits.
- Who are Wellesley Pharmaceuticals's investors?
- Wellesley Pharmaceuticals's investors include Keiretsu Forum.
- How much funding has Wellesley Pharmaceuticals raised?
- Wellesley Pharmaceuticals has disclosed $4.7M raised across 2 rounds.
- Where is Wellesley Pharmaceuticals headquartered?
- Wellesley Pharmaceuticals is headquartered in Newtown, US.